Overview

Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The objective of the present study is to establish the long-term safety of an intra-articular injection of human mesenchymal stem cells (hMSCs) (Chondrogen).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mesoblast International Sàrl